US Bancorp
PROK icon

US Bancorp’s ProKidney PROK Stock Holding History

US Bancorp’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$242 – 4176
2025
Q3 		$242 Sell
100
-100
-50% -$266 ﹤0.01% 3931
2025
Q2 		$118 Buy
+200
New +$156 ﹤0.01% 4107
2025
Q1 		– Sell
-693
Closed -$1.17K – 4330
2024
Q4 		$1.17K Sell
693
-320
-32% -$577 ﹤0.01% 3941
2024
Q3 		$1.95K Sell
1,013
-1,106
-52% -$2.51K ﹤0.01% 3794
2024
Q2 		$5.21K Buy
+2,119
New +$5.69K ﹤0.01% 3500
2023
Q4 		– Sell
-2,101
Closed -$9.62K – 4112
2023
Q3 		$9.62K Hold
2,101
– – ﹤0.01% 3189
2023
Q2 		$23.5K Buy
2,101
+1,692
+414% +$18K ﹤0.01% 2893
2023
Q1 		$4.63K Sell
409
-591
-59% -$6.29K ﹤0.01% 3544
2022
Q4 		$6.86K Hold
1,000
– – ﹤0.01% 3411
2022
Q3 		$9K Buy
+1,000
New +$8.7K ﹤0.01% 3415

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

US Bancorp's PROK Position: Q4 2025 in Review

US Bancorp sold out of ProKidney (PROK) in Q4 2025, closing a stake of 100 shares — an estimated $242 sold.

US Bancorp first reported a position in PROK in Q3 2022 and held it in 10 quarters. The position peaked at $23.5K in Q2 2023. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

  • US Bancorp reported no remaining ProKidney position as of Q4 2025 after selling out during the quarter.
  • US Bancorp sold 100 ProKidney shares in Q4 2025, an estimated $242.
  • US Bancorp first reported a position in ProKidney in Q3 2022 and held it in 10 quarters.
  • US Bancorp's ProKidney position peaked at $23.5K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on US Bancorp's 13F filing for Q4 2025, filed 30 Jan 2026.